TNF-alpha Safety Update
Adverse Events (>10%)
–
Serious infections
–
Infusion reactions
–
Auto-Antibodies
–
Cardiovascular complications
–
Neurologic complications
–
Hematologic complication
–
Malignancy
–
Mortality
Integrated Safety Summary, 2005.